Results 81 to 90 of about 16,901 (313)

Mpox infection of stromal cells and macrophages of macaque with endometriosis

open access: yesScientific Reports
The mpox outbreak of 2022–2023 represented a new global health challenge and recognition of mpox as a sexually transmitted disease. The majority of cases were reported in men who have sex with men (MSM), but women are also susceptible, especially during ...
Joshua M. Hall   +7 more
doaj   +1 more source

Global prevalence and correlates of mpox vaccine acceptance and uptake: a systematic review and meta-analysis

open access: yesCommunications Medicine
Background Vaccination has been recommended as one of the most potent ways of controlling the mpox (formerly, monkeypox) outbreak, particularly among high-risk groups.
S. K. Sulaiman   +5 more
semanticscholar   +1 more source

Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons — 43 U.S. Jurisdictions, July 31–October 1, 2022 [PDF]

open access: gold, 2022
Amanda B. Payne   +22 more
openalex   +1 more source

Mpox and the Ethics of Outbreak Management: Lessons for Future Public Health Crises

open access: yesDeveloping World Bioethics, EarlyView.
ABSTRACT Mpox, first identified in captive monkeys in 1958 and recognized in humans by 1970 in the Democratic Republic of Congo, was historically confined to sporadic zoonotic outbreaks in Central and West Africa. These outbreaks, often driven by rodent‐to‐human transmission in resource‐limited settings, reflect persistent systemic health disparities ...
Adetayo E. Obasa   +3 more
wiley   +1 more source

Robustly detecting mpox and non-mpox using a deep learning framework based on image inpainting

open access: yesScientific Reports
Due to the lack of efficient mpox diagnostic technology, mpox cases continue to increase. Recently, the great potential of deep learning models in detecting mpox and non-mpox has been proven. However, existing methods are susceptible to interference from
Yujun Cao   +6 more
doaj   +1 more source

Incubation period and serial interval of mpox for the 2022 global outbreak compared to historical (pre-2022) estimates [PDF]

open access: yes
Better understanding changes to the transmission dynamics of mpox requires comparing recent estimates of key epidemiological parameters, the incubation period and serial interval, with historical data.
Akhmetzhanov, Andrei   +6 more
core   +2 more sources

Breakthrough Infections after Postexposure Vaccination against Mpox [PDF]

open access: bronze, 2022
Michaël Thy   +26 more
openalex   +1 more source

Distinct T Cell Receptor Clonotypes in the Sardinian Population Highlight the Role of Mucosal‐Associated Invariant T Cells and Invariant Natural Killer T Cells in Multiple Sclerosis

open access: yesImmunology, EarlyView.
Antigen‐specific TCR‐α clonotype frequencies in MS and HC groups. (A) Heatmap of CDR3 TCR‐α clonotype annotations. (B) Comparative analysis of CDR3 TCR‐α clonotypes targeting viral and autoimmune‐related antigens, including VP22, p65, NS4B, MLANA, M1, HA and BST2. NS3‐HCV‐specific CDR3 clonotypes are significantly enriched in MS patients.
Jiaxin Shen   +6 more
wiley   +1 more source

Therapeutics for treating mpox in humans

open access: yesCochrane Database of Systematic Reviews, 2023
Mpox was declared a Public Health Emergency of International Concern (PHEIC) by the World Health Organization (WHO) on 23 July 2022, following the identification of thousands of cases in several non-endemic countries in previous months. There are currently no licenced therapeutics for treating mpox; however, some medications may be authorized for use ...
Fox, Tilly   +5 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy